Ovintiv Operating Cash Flow increased by 10.7% to $1.06B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 21.0%, from $873.00M to $1.06B. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 3.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $750.00M | $812.00M | $740.00M | $685.00M | $1.34B | $962.00M | $875.00M | $1.07B | $831.00M | $906.00M | $1.36B | $659.00M | $1.02B | $1.02B | $1.02B | $873.00M | $1.01B | $812.00M | $954.00M | $1.06B |
| QoQ Change | — | +8.3% | -8.9% | -7.4% | +96.2% | -28.4% | -9.0% | +22.1% | -22.2% | +9.0% | +50.3% | -51.6% | +54.8% | +0.2% | -0.2% | -14.4% | +16.0% | -19.8% | +17.5% | +10.7% |
| YoY Change | — | — | — | — | +79.2% | +18.5% | +18.2% | +55.9% | -38.2% | -5.8% | +55.7% | -38.3% | +22.7% | +12.8% | -25.1% | +32.5% | -0.7% | -20.5% | -6.5% | +21.0% |